Clinical Trial: Efficacy of a Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use: A Clinical, Subjective, and Trichogram Evaluation

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07783113) titled 'Efficacy of a Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use: A Clinical, Subjective, and Trichogram Evaluation' on Aug. 20.

Brief Summary: A single-center, open-label clinical study to evaluate whether a dietary supplement can reduce hair loss in women with GLP-1-associated telogen effluvium. Participants will use the supplement for 120 days. Researchers will evaluate hair loss, hair density, and hair growth through clinical assessments, hair measurements (trichogram), and participant questionnaires.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Alopecia

Intervention: ...